March 1, 2022 - BMS
Can CE get 340B pricing if they share claims data?
“Yes but conditions apply:
– Applies only to IMiDs (Revlimid, Pomalyst and Thalomid)
– Wholesaler has to be ABC
– CE cannot already be part of BMS network through their in-house pharmacy for the IMiDs
– If all conditions are met then CE can designate one BMS approved specialty pharmacy. BMS will then provide a claims submission template to the entity. The CE should email the completed template to BMCCelgene340BRX@web.bms.com. See link below for the complete list of SPs approved to dispense these IMiDs: https://www.bms.com/patient-and-caregivers/risk-evaluation-and-migration-strategies-rems.html”
Are system owned contract pharmacies exempted from this policy?
Yes
Can CEs with no in-house pharmacy designate a contract pharmacy for 340B pricing access?
“Yes (CEs can designate 2 CPs – one for non-IMiD products and one for IMiD products) but
certain conditions apply:
– Applies only to IMiDs (Revlimid, Pomalyst and Thalomid)
– Wholesaler has to be ABC
– If both conditions are met then CE can designate one BMS approved specialty pharmacy. See the link below for the complete list of SPs approved to dispense these IMiDs: https://www.bms.com/patient-and-caregivers/risk-evaluation-and-migration-strategies-rems.html”
Drugs affected by this policy:
All Products (no exceptions)
Policy applies to what entity types?
Policy applies to hospitals covered entities only. Federal grantees are exempted from this policy.